Ancy Kunnumpurath
Internal Medicine · la Fayette, NYNPI 1629396502
Payments from drug & device makers
Across 142 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$414
- Novo Nordisk$344
- Merck$275
- GSK$255
- AstraZeneca$230
- AbbVie$216
- plus $889 from 15 others
What the payments were for
- Food & beverage$2,623100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 25 | $414 |
| Novo Nordisk | 19 | $344 |
| Merck | 14 | $275 |
| GSK | 13 | $255 |
| AstraZeneca | 14 | $230 |
| AbbVie | 9 | $216 |
| Abbott | 7 | $146 |
| Pfizer | 6 | $115 |
| Exact Sciences | 4 | $96 |
| Grifols USA, LLC | 6 | $96 |
| Boehringer Ingelheim | 4 | $80 |
| Amarin Pharma, Inc. | 5 | $77 |
| Bayer | 3 | $56 |
| Johnson & Johnson | 3 | $46 |
| Inspire Medical Systems, Inc. | 2 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Amgen | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$2,623 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 53 | $51,554 |
| JardianceEmpagliflozin | 32 | $39,932 |
| EliquisApixaban | 12 | $17,415 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $13,793 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $9,494 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $7,926 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $7,003 |
| Incruse ElliptaUmeclidinium Bromide | 20 | $6,926 |
| VascepaIcosapent Ethyl | 17 | $6,846 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 51 | $6,570 |
| Arnuity ElliptaFluticasone Furoate | 19 | $6,164 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 167 | $4,843 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $4,820 |
| Omeprazole | 184 | $2,157 |
| Gabapentin | 105 | $1,405 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $344 | $51,55453 claims |
| Boehringer IngelheimJardiance | $80 | $39,93232 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta | $255 | $33,88674 claims |
| PfizerEliquis | $115 | $17,41512 claims |
| AstraZenecaSymbicort | $230 | $4,82017 claims |
| AbbVieSynthroid | $216 | $1,03815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in la Fayette
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.